
Medications
Ozempic, Wegovy, Zepbound, Mounjaro
Monthly Cost
$199/mo membership
Speed to Start
Moderate
FDA-Approved Meds
Est. 2020
About Calibrate
Calibrate markets itself as a “metabolic reset” program, and the framing is deliberate — this isn’t just a GLP-1 prescription service. Founded in 2020, Calibrate wraps FDA-approved brand-name medications around a comprehensive coaching and clinical support system designed to produce lasting metabolic change, not just short-term weight loss.
The medication offerings are exclusively brand-name and FDA-approved: Ozempic, Wegovy, Zepbound, and Mounjaro. No compounded alternatives are involved. At $199/month for membership (medication separate, insurance accepted), Calibrate positions itself as a premium-but-accessible option, especially for patients with insurance coverage.
The clinical program is where Calibrate truly differentiates. Every member gets 1:1 video coaching, lab testing, and dietitian access — the trifecta of clinical features that our scoring model rewards most heavily. The metabolic reset framework goes beyond medication to address sleep, exercise, emotional health, and nutrition as interconnected drivers of metabolic function.
With a 4.6 Trustpilot rating across 1,200+ reviews and an A- BBB rating, Calibrate’s reputation is strong. The combination of high clinical quality, high support, and solid trust metrics makes this one of the most well-rounded programs in our directory.
The moderate onboarding speed reflects the thorough intake process — Calibrate doesn’t rush patients through. For those willing to invest in a program that treats weight loss as a metabolic health issue rather than a quick-fix prescription, the pace is a feature, not a bug.
At a Glance
Medications Offered
Ozempic, Wegovy, Zepbound, Mounjaro
Brand-Name
Cost & Insurance
- Monthly: $199/mo membership
- 6-month estimate: $1,194 membership over 6 months + medication
- Insurance: Yes
- Self-pay: Yes
Clinical Features
- Lab testing: Yes
- Dietitian access: Yes
- Verified Pharmacy: N/A — Brand-name only (Ozempic, Wegovy, Zepbound, Mounjaro)
- BBB Rating: A-
Delivery & Access
- Format: Both
- Nationwide telehealth: Yes
- Speed: Moderate
- Spanish-speaking providers: Not available
Start your GLP-1 weight loss journey with Calibrate today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. Our scores are based on verified data and standardized criteria.
What the Calibrate Intake Looks Like
We walked through Calibrate’s “Two Minute Quiz” ourselves, from the state-of-residence screen through the insurance gate and final contact details. Calibrate is a year-long metabolic health program with Calibrate clinicians, 1:1 coaching, and lab work — the quiz is a screening funnel for that program, not a medication storefront.
High-signal contraindication screen. Explicit gates for eating disorder, substance abuse, active cancer, three pancreatitis sub-types, 18-month bariatric recency, Type 1 / insulin pump, and MTC/MEN. Missing family history on MTC/MEN2, validated PHQ, allergies, and current medication list.
Higher than average. The quiz is short, but enrollment is a year-long program commitment, insurance is gated (Kaiser is rejected outright), and pricing is disclosed later. Calibrate is selling a program, not a prescription.
The 8 Stages
Clinical Safety Screens Performed
Most GLP-1 intake forms check MTC/MEN2, pancreatitis, and pregnancy and call it a day. Calibrate adds active eating disorder, active substance abuse or dependency, active cancer treatment, bariatric surgery in the past 18 months, current insulin pump use, and three distinct pancreatitis sub-types (recent, idiopathic, and GLP-1-induced). That level of differentiation on pancreatitis alone is rare. Calibrate is also one of the very few platforms that gates on a current eating disorder — a screen that should arguably be standard across the whole category given the off-label appetite-suppression risk.
Calibrate sells a year-long metabolic health program, not a monthly medication subscription. The quiz closes by capturing a lead — first name, last name, email, phone — rather than booking an appointment or loading a checkout. Medication choice is determined later in the clinician appointment based on labs, BMI, and insurance coverage; the patient never picks the drug from a shelf. The program includes 1:1 video coaching, a Calibrate clinician, a holistic curriculum, and results-or-money-back. Patients evaluating Calibrate should expect a pricing conversation and an enrollment call after submitting the quiz, not a same-day prescription.
When we selected Kaiser as the insurance carrier, Calibrate produced an immediate hard rejection: “Unfortunately, we’re not able to accept members covered by Kaiser insurance. We’ve found that most Kaiser plans are unable to work outside of their network.” The rejection screen offers a “View Top Tips” fallback that opens a long-form food / exercise / sleep / emotional-health tips page with actionable guidance, rather than disappearing the patient into a dead-end. This kind of explicit, upfront gating — and the willingness to say “we can’t serve you, here’s free content instead” — is more transparent than the industry norm of capturing a lead and figuring it out later.
MTC and MEN are captured as personal history only — there is no explicit family history screen, which is a notable gap given that the FDA black-box warning applies to both. The quiz also does not include a validated PHQ-2 or PHQ-9 depression instrument or any explicit mental health question (though an active eating disorder is a hard gate), a structured current medication list, an allergy capture, a blood pressure reading, an ID upload, or a phone OTP. Diet and exercise history are intentionally deferred to the program curriculum and 1:1 coaching rather than surfaced in the quiz itself.
Source: GLP-1.Reviews editorial walkthrough on April 13, 2026. We completed every screen of the Calibrate Two Minute Quiz using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens joincalibrate.com in a new tab. We may earn a commission if you start treatment through this link, at no additional cost to you.









